| BioWorld

Stock Winners and Losers For The Week

Clinical Trial Update: October 2002

Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: October 2002

FDA Submissions, Approvals And Other Actions: October 2002

BioWorld Stock Report For Public Biotechnology Companies

Cash-Positive Companies Have Best Chance Of Impressing VCs

Walk into any funding firm and you will see mountains of papers summarizing this company's dream and that company's vision. (BioWorld Financial Watch) Read More

Money Raised Year To Date

BioWorld

Nov. 18, 2002

Stock Winners and Losers For The Week

Clinical Trial Update: October 2002

Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: October 2002

FDA Submissions, Approvals And Other Actions: October 2002

BioWorld Stock Report For Public Biotechnology Companies

Cash-Positive Companies Have Best Chance Of Impressing VCs

Money Raised Year To Date

Today's news in brief

Today's news in brief

News in brief

BIO 2025: Makary lays out FDA’s path, launches pilot review program

New orphan drug, CSL’s garadacimab, cleared for hereditary angioedema